Static Chart Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 16:00:00 2026-07-28 EDT			5-day change	1st Jan Change
2.870 ^USD	+1.77%		-3.69%	+4.36%

07-28	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
07-17	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

Duration

Period